News|Articles|May 1, 2003

Coreg (Carvedilol) GlaxoSmithKline

b-blocker indicated for reducingcardiovascular mortality


Related to this article

Medicare Part D redesign reshapes market
Part D enrollment has shifted: standalone plan offerings are down 22%, while special needs plans grew 21%, reshaping competition among fewer, larger sponsors nationally, finds an analysis by IPD Analytics.